CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 110 enrolled
Drug / intervention
Acetaminophen +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04018612
NCT04018612Phase 2Completed

A Randomized, Double-Blind, Multi-Dose, Single-Site, Placebo- and Active-Controlled, Efficacy, Tolerability, Safety and Pharmacokinetic Study of Two Different Dosing Regimens of Acetaminophen in Post-Surgical Dental Pain.

Nevakar, Inc.·interventional·Posted Jul 12, 2019·Updated Mar 29, 2022

In Brief

A Phase 2 clinical trial evaluating Acetaminophen and Placebo for Pain, Postoperative and Dental Pain. Completed, enrolled 110 participants across 1 site.

Detailed Summary

To assess the safety, tolerability, analgesic, efficacy and pharmacokinetics of high dose acetaminophen relative to placebo and low dose acetaminophen relative to placebo over a 24 hour period in patient experiencing moderate to severe pain following the surgical removal of third molar.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2020202120222023202420252026
First PostedJul 12, 2019
Enrollment StartApr 25, 2019
Primary CompletionJul 26, 2019
Study CompletionAug 15, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.0 years ago

Interventions

Acetaminophendrug

Acetaminophen is an analgesic and antipyretic

Placeboother

Saline